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ABSTRACT 
One in every nine births in the United States are preterm births (CDC, 2012), and 
of those, the leading cause is microbial infection. Current pharmacological treatments for 
these microbial infections have been shown to have serious side effects and low 
potencies. Alternatively, Moringa oleifera (MO) has been shown to exhibit potent anti-
inflammatory and -bacterial activities with minimal side effects. Here, we test the 
effectiveness of MO as an alternative treatment to pharmacological-based inflammation 
therapies and its potential use in preterm births. Specifically, the effectiveness of (MO) 
whole leaf extract is tested against inflammation induced by lipopolysaccharide (LPS). 
Following specific treatments [2 hour pretreatment with MO(4.8 µg/50 µL methanol, per 
os, followed by 2 hour treatment with LPS (100 µg/50 µL 1X PBS, i.p.)] of pregnant 
mice (day 15), cervical tissues were harvested and mRNA expression of angiogenic 
factors [vascular endothelial growth factor, VEGF); VEGF receptor 1, Flt-1; and VEGF 
receptor 2, KDR] were analyzed using real-time PCR (qRT-PCR). The results show that 
MO whole methanolic extract largely down regulates expression of angiogenic factors 
VEGF and KDR mRNAs, while it had no significant effect on the expression of Flt-1. 
Based on this data, we can conclude that MO may be used to prevent inflammation 
induced preterm labor by decreasing expression of certain angiogenic factors, specifically 
VEGF and KDR. 
KEYWORDS 
Moringa	oleifera;	inflammation;	preterm	birth;	vascular	endothelial	growth	factor	
(VEGF),	Flt-1,	KDR. 
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INTRODUCTION 
One of the most common causes of perinatal morbidity is premature birth (Read et al., 
2007). Along with other adverse events, such as preeclampsia, preterm labor in the USA 
results in over 400,000 premature births annually and additionally affects 11% of all live 
births and is the leading cause of neonatal mortality (Boggess, 2005).  Of these preterm 
births, 40%-60% are associated either directly or indirectly with infection (Newton, 
2005). Intrauterine infections associated with these pregnancies ascend from the vagina, 
and may breach the cervical barrier to infect the fetal membranes or the amniotic fluid 
(Keelan et al., 2016). When this infection occurs, an inflammatory response takes place 
typically as chorioamniotitis, which is a possible cause of preterm labor and birth (Keelan 
et al., 2016). In addition to inflammation resulting from bacterial infection, preterm birth 
can also be caused by environmental factors, genetics, or other unknown causes (Newton, 
2005). Of these potential causes, premature cervical ripening precedes the onset of 
preterm labor in the majority of cases (Mahendroo, 2012).  Studies in our lab have also 
implicated angiogenic factors in the ripening process of the cervix, in particular 
cytokines, such as vascular endothelial growth factor (VEGF) and its two receptors, KDR 
and Flt-1, respectively (Mowa et al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 
2015). 
VEGF is an angiogenic factor that induces mitosis and growth of vascular endothelial 
cells of the arteries, veins and lymphatics (Ferrara, 2001). It is one of the main growth 
factors involved in the development of new blood vessels from pre-existing ones, a 
process termed angiogenesis (Mowa et al., 2004).  VEGF has two receptors that bind it 
with high affinity. The first is Flt-1, an fms-like tyrosine kinase, and the second is KDR, 
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which has a kinase domain region (Ferrara, 2001). VEGF and its receptors work together 
along with other angiogenic factors to induce vascularization and growth in various 
organs throughout the body (Ferrara, 2001). 
Throughout the course of pregnancy the cervix must remain closed and firm in order 
to prevent the immature passage of the infant through the birth canal resulting in preterm 
birth (Mahendroo, 2012). As pregnancy approaches full term, the cervix must become 
flexible and open to allow for delivery. This process is called cervical remodeling 
(Mahendroo, 2012). Cervical remodeling is one continuous process that can be divided 
into four different phases, namely softening, ripening, dilation/labor, and post partum 
repair (Read et al., 2007).  The first stage of softening occurs by day 12 in mice and 
during the first trimester in humans, and is characterized by a slow incremental decrease 
in tissue compliance that will continue until birth (Timmons et al., 2010). With regards to 
preterm labor and birth, the most important stage to evaluate is the second stage of 
ripening. During this stage, there is an observed increase in hyaluronan content, changes 
in collagen matrix and distribution of inflammatory cells, as well as increased tissue 
growth and hydration (Read et al., 2007). This ripening process is brief and occurs just 
before birth, i.e., hours in mice and weeks or days in humans (Timmons et al., 2010).  
Following ripening, the cervix can now dilate sufficiently to allow passage of the fetus 
for birth (Timmons et al., 2010). The final phase is postpartum repair, which involves 
recovery of tissue integrity and competency after birth (Mahendroo, 2012; Stanley et al., 
2015). 
Based on previous studies from our lab and others, there is a high likelihood that 
changes occurring in the cervix during remodeling, and ripening in particular, may 
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involve angiogenesis (Mowa et al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 
2015, Stanley et al., 2015). During the first trimester, the concentration of VEGF in 
maternal serum increases (Wheeler, 1999) corresponding to the first stage of cervical 
remodeling or softening (Timmons et al., 2016). During the second stage of cervical 
remodeling an inflammation-like process occurs which can in part be attributed to 
angiogenesis (Mowa et al., 2004). During cervical ripening, the density of immune cells, 
including neutrophils, eosinophils and macrophages, change (Mahendroo, 2012). 
Collectively these changes, along with recruitment and mobilization of other leukocytes 
into the connective tissue of the cervix, are preceded by structural changes to the 
vasculature (Mowa et al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 2015, Stanley 
et al., 2015). Alterations to the vasculature during this stage resemble VEGF-induced 
vascular changes, including angiogenesis, vascular leakage and vasodilation (Mowa et 
al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 2015).  Subsequently, pathological 
increase in levels of VEGF and other angiogenic factors in the cervix could lead to 
premature ripening and preterm birth. 
Moringa Oleifera (MO), commonly called the “drumstick” or “horseradish tree,” is a 
perennial angiosperm plant that is distributed throughout the tropics and subtropics 
around the world (Mbikay, 2012). This member of the monogeneric family is indigenous 
to India, Pakistan, Bangladesh and Afghanistan (Tan et al., 2015).  Historically, MO 
leaves have been used for traditional medicine, as well as a nutritious food source in Asia 
and Africa (Waterman et al., 2014). Almost all plant parts of MO contains bioactive 
compounds, including the leaves, roots, bark, gum, flowers, fruits, seeds and seed oil 
(Tan et al., 2015). Various bioactive compounds in MO, such as flavonols and phenolic 
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acids, have been linked to anti-inflammatory, antibacterial and antioxidant properties 
(Waterman et al., 2014). In addition to these phytochemicals, there are also secondary 
metabolites, including vitamins, carotenoids, minerals, sterols, amino acids, alkaloids and 
glycosides, which contribute to a wide range of pharmacological activities from wound 
healing to protection against oxidative stress in an in vivo animal model of Alzheimer’s 
disease (Fard et al., 2015). 
In the present study, we evaluate the effects of MO on angiogenesis by examining the 
mRNA expression of vascular endothelial growth factor (VEGF) and its two receptors in 
a day 15 pregnant mouse model of preterm labor. We hypothesize that MO will diminish 
the gene expression of VEGF and its receptors, Flt-1 and KDR, thereby attenuating 
premature cervical ripening and subsequently preterm birth. 
 
MATERIALS AND METHODS 
Animals 
Types of animals used and conditions 
 In the present study, non-pregnant and pregnant ICR [CD-1(R)] were obtained 
from Harlan and used for experimentation. Pregnant mice used were day 15 of gestation, 
while non-pregnant were ovariectomized (ovaries were removed) at least seven days 
prior to the beginning of the study. Housing conditions for animals were maintained at 
constant room temperature with a 12:12 hour light and dark cycle. The animals were 
allowed free access to food and water at all times. Treatments were given, as described 
below, and mice were then killed using a lethal dose of pentobarbital sodium 
intraperitoneally (IP) (0.2mg/g) (Euthasol®, Virbac Animal Health, Fort Worth, Texas). 
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This was immediately followed by a trans-cardio perfusion using 0.9% normal saline 
solution before harvesting of the cervical tissues. After tissue harvest, the cervical tissues 
were then stored at -80°C until processing. Tissues were processed and analyzed using 
quantitative real-time polymerase chain reaction (qRT-PCR).  
 
Ovariectomy (Ovary Removal) 
 Prior to use in the study, non-pregnant mice, approximately 6 months of age, were 
ovariectomized. Animals were anesthetized using a mixture of xylazine and ketamine 
(43–129 mg ketamine and 8.6–26 mg xylazine/g), which were administered 
intramuscularly (IM). To avoid post-surgical infection, the animals were injected with 
Baytril® (Bayer, Leverkusen, Germany) (5mg/kg) antibiotic. A seven-day post-surgery 
waiting period was allowed in order to eliminate possible residual ovarian sex steroid 
hormones. At the time of tissue harvest, animals with signs of residual sex steroid 
hormones and large uterine size, were eliminated from the study. 
 
Solvent Optimization Study 
 Before the use of MO extract in the present study, a series of experiments were 
conducted to determine the whole leaf solvent extracts with the most potent anti-
inflammatory activities. The extracts included 100% ethanol, 80% hydro-ethanolic 
solution, methanol, butanol, and water. Non-pregnant ovariectomized mice were used in 
these optimization studies. Using a pre-optimized dosage of 4.8 µg/µL of respective MO 
extracts, 50 µL (240 mg/mouse) of MO was administered IP (n=4) to non-pregnant mice 
(per os for pregnant mice). The mice were then injected with lipopolysaccharide (LPS) 
(25 µg/50 µL) IP two hours after treatment with MO extract, and one hour prior to 
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cervical tissue harvest. The mice were euthanized using a lethal dose of pentobarbital 
sodium (0.2mg/g) (Euthasol®, Virbac Animal Health, Fort Worth, Texas), followed by 
trans-cardio perfusion with 0.9% normal saline solution. The tissues were harvested and 
snap frozen and stored at -80°C until further experimentation and analysis. It was 
determined that methanol was the optimal solvent, based on the mRNA expression of key 
pro-inflammatory factors involved in preterm labor, and was, therefore, used in all 
subsequent studies. 
 
Pregnant Mice Study 
 At day 15 of gestation, pregnant mice were treated with optimized MO extract 
(Methanol) prior to LPS administration, overall, as described earlier under non-pregnant. 
This was done in order to observe the effects of MO on expression of key angiogenic 
factors, including vascular endothelial growth factor (VEGF) and its receptors one (Flt-1) 
and two (KDR). The mice were treated as described in the following groups: a) Negative 
control: 1X PBS (50 µL/mouse of vehicle per os); b) Positive control: LPS (100 µg/50 
µL, ip), or c) pretreated with MO methanolic extract (240 mg/mouse, per os) followed by 
LPS (100 µg/50 µL, ip) two hours later (n=4). Mice were euthanized one hour after LPS 
injection using a lethal dose of pentobarbital sodium (Euthasol®, Virbac Animal Health, 
Fort Worth, Texas) followed by a trans-cardio perfusion with 0.9% normal saline solution 
before harvesting of the cervical tissues. After cervical tissue harvest, these tissues were 
stored at -80°C until processing and analysis using quantitative real time polymerase 
chain reaction (qRT-PCR). 
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Techniques Used 
Gene Expression 
 Following the animal treatments and tissue harvest, the total RNA from individual 
mice cervices were isolated using an RNeasy Mini Kit (Oiagen, Valencia, CA). The RNA 
concentrations were then obtained using a Nanodrop Spectrophotometer (NanoDrop 
3000, Thermo Scientific) and recorded. The isolated RNA was then used to analyze 
changes in the gene expression of angiogenic factors VEGF, KDR, and Flt-1. 
 Reverse Transcription: Using the previously isolated RNA, complementary DNA 
was synthesized and amplified through reverse transcription using reagents obtained from 
Applied Biosystems and an Eppendorf Master Cycler (Hamburg, Germany), as described 
here: 1 µg of total RNA in 9.5 µL of RNase-free water was incubated for 5 minutes in a 
water bath set at 65°C and the total RNA was then cooled at RT for 10 minute before 
adding the following mixture to each sample of total RNA: 9.5 µL of reverse 
transcription master mix consisting of 2 µL RT buffer, 2 µL MgCl2, 2 µL dNTP, 0.5 µL 
RNase inhibitor, 2 µL RNase-free water, and 1 µL random hexamers. Finally, 1µL 
MuLV reverse transcriptase was added to each total RNA sample, excluding a non-
template tube, which was used as a control for DNA contamination. The final mixtures 
were then placed in the Eppendorf thermocycler and allowed to run for 10 min at 25°C, 
for 2 hours at 42°C, for 5 min at 95°C and stored at 4°C.    
 Quantitative RT-PCR: In order to quantify the relative expression of the 
angiogenic factors VEGF, Flt-1, and KDR qRT-PCR was used. The mRNA levels of 
these genes in the cervix of pregnant mice at day 15 of pregnancy were analyzed. Using 
the previously synthesized cDNA, pre-designed TaqMan® Gene Expression Assays 
	 8	
(Applied Biosystems, Foster, CA) were utilized to amplify the genes of interest using an 
Applied Biosystems 7500 Real-time PCR system (Foster, CA). A qRT-PCR master mix 
was prepared by carefully mixing the following reactions: 12.5 µL 2X Taqman® 
Universal PCR Master Mix, 1.25 µL gene-specific TaqMan® Gene Expression Assay, 
and 6.25 µL qRT-PCR-grade RNase-free water per sample. This mixture was then 
pipetted into a 96-well plate in a quantity of 20 µL along with 5 µL of cDNA per well. 
The Real-time PCR system was pre-set to run for 2 min at 50 °C, 10 min at 95°C, 40 
cycles of 95°C for 15 seconds and 60°C for 60 seconds. In order to obtain threshold cycle 
values, the GeneAmp 7300HT sequence detection system software was utilized. These 
values were used to calculate the relative expression levels of target angiogenic factors as 
compared to the mean of the endogenous control gene, Gus b. 
Statistical Analysis 
Student’s t test and ANOVA (single factor) were used to analyze the data obtained in 
these studies. p-values equal to or less than 0.05 were considered to be statistically 
significant. 
RESULTS 
MO extract down regulates expression of VEGF mRNA in mouse cervix 
 Following LPS, mRNA expression of VEGF in mouse cervix increased 
approximately ten fold as compared to the negative control (Figure 1). When pre-treated 
with MO followed by LPS, there was almost a nine fold decrease in VEGF expression, 
comparable to levels of the negative control (Figure 1).  
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MO extract down regulates expression of KDR mRNA in mouse cervix 
 Treatment of mice with LPS alone increased KDR mRNA expression by 
approximately 0.75 fold compared to the negative control (Figure 2), based on qRT-PCR 
analysis. When mice were pre-treated with MO followed by LPS, MO blocked LPS and 
levels of KDR mRNA were down-regulated to those comparable to the negative control 
by 0.75 fold (Figure 2). 
MO extract has no significant effect on expression of FLT-1 mRNA expression in 
mouse cervix 
 Using qRT-PCR data, it was shown that LPS increased Flt-1 mRNA expression 
approximately three fold when compared to the negative control (Figure 3).  Pre-
treatment with MO failed to block the effects of the subsequent LPS injection on Flt-1 
mRNA expression (Figure 3). 
DISCUSSION 
 Pregnancy is a delicate process and because infection-induced inflammation is 
one of the leading causes of preterm labor, finding a safe and effective natural-based 
treatment is essential. The key findings of the present study indicate that methanolic MO 
whole leaf extract tends to down regulate various angiogenic factors in mice cervices, 
including VEGF and KDR. While this MO extract down-regulates these angiogenic 
factors, it has no apparent effect on FLT-1. 
In the present study, a decrease in VEGF mRNA was observed when MO was 
used as a pre-treatment before inducing inflammation with LPS. Our observations are 
consistent with an earlier study that reported that MO inhibits inflammatory and 
angiogenic gene expression, including VEGF (Gupta et al., 2013). The aim of the study 
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by Gupta et al., (2013) was to develop alternative treatments for streptozotocin-induced 
diabetic rats. They also discovered that MO was able to prevent dilation of retinal vessels 
in retinae that were treated with the plant extract (Gupta et al., 2013). It is important to 
note that this study differs from the present study in that the retinae were treated with MO 
and not the whole animal. Because VEGF is one of the body's most powerful 
vasodilators, the prevention of vessel dilation following MO treatment was interpreted as 
an indication of decreased VEGF expression. Equally, during cervical remodeling, our 
lab has speculated that VEGF could have the same effects, i.e., promoting vasodilation,. 
(Mowa et al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 2015). Such a pattern in 
VEGF effect is not restricted to the cervix and retina but appears to be more widespread 
(Mowa et al., 2004). For instance, withdrawal of VEGF has been shown to induce 
regression of vasculature in a variety of physiological and pathological circumstances 
(Ferrara, 2001). In contrast, the accompanying changes that occur resemble those in other 
organs induced by VEGF, including angiogenesis, vascular leakage and vasodilation 
(Mowa et al., 2004). For now, the underlying mechanism by which MO decreases the 
mRNA expression of this dynamic molecule (VEGF) is unknown. We speculate that the 
inhibition of this angiogenic factor, could potentially be utilized to modulate premature 
cervical remodeling and subsequently preterm birth. 
 Similarly, MO was also able to down-regulate VEGF’s second receptor, KDR. 
However, it had no apparent effect on the first receptor, Flt-1. Previous studies have 
shown that the expression of Flt-1 is overall specific to endothelium, while KDR is 
largely localized in capillaries and endothelial of blood vessels (Waltenberger et al., 
1994). Our previous studies and by others, have shown a much broader cell type 
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distribution beyond the vascular cells, including fibroblasts and epithelial cells (Mowa et 
al., 2004, 2008, Donnelley et al., 2013, Ohashi et al., 2014, Stanley et al., 2015). With 
such a broad cell type distribution, both receptors likely play an important role during 
pregnancy. Indeed, earlier knockout studies have shown that embryonic mice lacking 
VEGF were unable to develop normal vasculature and resulted in abortions (Wheeler, 
1999). Similarly, mice that were deficient in only KDR did not develop differentiated 
endothelial cells or organized blood vessels. While mice deficient in only Flt-1 were 
found to possess differentiated endothelial cells, they developed large disorganized 
vessels (Zachary et al., 2001). Collectively, these earlier findings suggest that both 
receptors must be present to develop normal vasculature and differentiated endothelial 
cells. The present findings that MO fails to diminish Flt-1 mRNA expression in mice 
cervices was unexpected, considering that Flt-1 has a much higher affinity for VEGF than 
for KDR (Mowa et al., 2004). For now, the underlying reasons for the differential effects 
of MO on the two VEGF receptors, as well as their implications, are unclear.  
As previously stated, in the United States and around the world a significant 
percentage of live births occur before full term and of those, infection is the leading 
cause. Unfortunately, there is currently no treatment that is both effective and safe for 
mother and fetus for these infections. In the present study we have demonstrated that MO 
can down-regulate both VEGF and its second receptor KDR. Based on other research, the 
down-regulation of these two molecules should be accompanied by the inhibition of 
premature cervical remodeling. In our most recent studies, MO was also found to 
decrease the expression of pro-inflammatory factors, such as TNFa, IL-6, as well as 
COXII proteins, which have all been linked to preterm birth.  Since MO is an edible 
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vegetable and has been used safely for thousands of years, including in pregnant women, 
it could potentially become a safe and effective treatment for infection or inflammation-
induced preterm birth.  
Although the findings of the present study show great promise for MO as a 
potential treatment option for preterm labor, it had limitations. One limitation is that the 
effect of MO used as a treatment after inflammation is already present was not analyzed. 
This data is based on the pretreatment of MO before inducing inflammation with LPS. 
The mRNA analyzed using qRT-PCR was based on a sample size of only four animals 
per treatment. While this was sufficient to establish preliminary results, in order to draw 
any major conclusions, the sample size must be greater, with more animals per treatment 
group. In addition to a small sample size, the other limitation of the study was that only 
mRNA expression was analyzed. Future studies should also analyze the expression and 
activities of proteins using various techniques, such as western blot and confocal 
microscopy. Lastly, in order to develop an effective treatment, we need to not only know 
that MO is able to modulate the angiogenic factors, but how it (MO) is able to do this. 
Also the possible interaction between the angiogenic factors and pro-inflammatory 
markers, such as Cox-II, TNFa and IL-6 would need to be investigated. Expansion of 
these studies in a pregnant animals would also be useful to determine the outcome of 
pregnancies in the treatment groups. 
Although there are yet a number of limitations to overcome and improvements to 
be made going forward before using MO as a preventative of preterm birth, the findings 
of this study show much promise. This is because VEGF and KDR have been implicated 
to play a role in cervical remodeling. By modulating these two angiogenic, as well as pro-
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inflammatory factors, it is very possible that MO may be used to prevent inflammation 
induced preterm birth in the future. 
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Figure 1. Effects of Moringa olefeira (MO) on the mRNA expression of VEGF in day 15 
pregnant mouse cervix, as shown by qRT-PCR. LPS up regulates expression of VEGF 
mRNA in the cervix of pregnant mouse and pre-treatment with MO attenuates the LPS-
induced expression of VEGF mRNA. n=4, * p < 0.05 LPS vs. Control; ** p < 0.05 MO+ 
LPS vs. LPS.                                 
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Figure 2. Effects of Moringa olefeira (MO) on the mRNA expression of KDR in day 15 
pregnant mouse cervix as shown by qRT-PCR. LPS up regulates expression of KDR 
mRNA in the cervix of pregnant mouse and pre-treatment with MO attenuates the LPS-
induced expression of KDR mRNA.  n=4, * p < 0.05 LPS vs. Control; ** p < 0.05 MO+ 
LPS vs. LPS, MO + LPS vs. Control. 
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 Figure 3. Effects of Moringa olefeira (MO) on the mRNA expression on FLT-1 in day 
15 pregnant mouse cervix as shown by qRT-PCR. LPS up regulates expression of Flt-1 
mRNA in the cervix of pregnant mouse and pre-treatment with MO did not attenuate the 
LPS-induced expression of Flt-1 mRNA.    n=4, * p < 0.05 LPS vs. Control.                          
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